by TractManager | Feb 22, 2021 | News
The Food and Drug Administration (FDA) has announced a recall of specific lots of the Boston Scientific EMBLEM S-ICD (Subcutaneous Implantable Cardioverter Defibrillator) due to a manufacturing error. The EMBLEM S-ICD is part of the Boston Scientific S-ICD System. The...
by TractManager | Feb 18, 2021 | Health Technology Assessment
Focus of the Report: This report evaluates the use of liquid sublingual immunotherapy (SLIT) for the treatment of allergic rhinitis in the United States.Technology Description: Liquid SLIT involves the daily administration of a diluted dose of an allergen under the...
by TractManager | Feb 18, 2021 | News
The Food and Drug Administration (FDA) has granted a Humanitarian Device Exemption (HDE) for the Patient Specific Talus Spacer 3D-printed talus implant (Additive Orthopaedics LLC).The Patient Specific Talus Spacer is the first in the world and first-of-its-kind...
by TractManager | Feb 16, 2021 | News
SANTA MONICA, CA and HOUSTON, TX – February 16, 2021 —(PRNEWSWIRE)— symplr, a leading global healthcare governance, risk management, and compliance (“GRC”) software-as-a-service (“SaaS”) company, backed by Clearlake Capital Group, L.P. (together with its affiliates,...
by TractManager | Feb 16, 2021 | Health Technology Assessment
Focus of the Report: This report focuses on Eustachian tube balloon dilation (ETBD) for treatment of adults with chronic Eustachian tube dysfunction (ETD) refractory to medical management (MM).Technology Description: ETBD is a minimally invasive transnasal endoscopic...
Recent Comments